Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zepp Health (ZEPP) Income from Non-Controlling Interests (2017 - 2024)

Zepp Health has reported Income from Non-Controlling Interests over the past 8 years, most recently at -$25000.0 for Q4 2024.

  • For Q4 2024, Income from Non-Controlling Interests fell 266.67% year-over-year to -$25000.0; the TTM value through Dec 2024 reached -$75000.0, down 13.64%, while the annual FY2024 figure was -$75000.0, 13.64% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2024 was -$25000.0 at Zepp Health, down from -$8000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $209000.0 in Q3 2020 and troughed at -$43000.0 in Q3 2021.
  • A 5-year average of $5700.0 and a median of -$23000.0 in 2022 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: surged 1800.0% in 2020 and later crashed 266.67% in 2024.
  • Year by year, Income from Non-Controlling Interests stood at -$8000.0 in 2020, then tumbled by 237.5% to -$27000.0 in 2021, then decreased by 3.7% to -$28000.0 in 2022, then skyrocketed by 153.57% to $15000.0 in 2023, then crashed by 266.67% to -$25000.0 in 2024.
  • Business Quant data shows Income from Non-Controlling Interests for ZEPP at -$25000.0 in Q4 2024, -$8000.0 in Q3 2024, and -$10000.0 in Q2 2024.